Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation

International Journal of Hematology

Volumn 85, Issue 1, 2007, Pages 70-72

  Suzuki, Nobuhiro ^a   Hatakeyama, Naoki ^a   Yamamoto, Masaki ^a   Mizue, Nobuo ^a   Kuroiwa, Yuki ^a   Yoda, Minami ^b   Takahashi, Junko ^c   Tani, Yoshihiko ^c   Tsutsumi, Hiroyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

Aspergillosis; Chronic granulomatous disease; McLeod phenotype; Reduced intensity conditioning; Umbilical cord blood transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLOMOXEF; FLUDARABINE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MICAFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYMYXIN B; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; KIDNEY INJURY; MALE; PHENOTYPE; PROGNOSIS; RARE DISEASE; REDUCED INTENSITY CONDITIONING; TREATMENT INDICATION; TREATMENT OUTCOME; VIREMIA;

ADULT; ASPERGILLOSIS; CORD BLOOD STEM CELL TRANSPLANTATION; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; MALE; PHENOTYPE; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33846678722     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH9706129     Document Type: Article

References (6)

1. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hematopoietic allograft: a survey of the European experience, 1985-2000. Blood. 2002;100:4344-4350.
2. Bielorai B, Toren A, Wolach B, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant. 2000;26:1025-1028.
3. Yoda M, Yoshida K, Ohyanagi N, et al. A case of X-linked chronic granulomatous disease associated with McLeod syndrome. J Jpn Pediatr Soc. 2006;110:38-41.
4. Horwitz ME, Barrett AJ, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med. 2001;344:881-888.
5. Bhattacharya A, Slatter M, Curtis A, et al. Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant. 2003;31:403-405.
6. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915-1919.